99 related articles for article (PubMed ID: 18923451)
1. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
Wu J; Nihal M; Siddiqui J; Vonderheid EC; Wood GS
J Invest Dermatol; 2009 May; 129(5):1165-73. PubMed ID: 18923451
[TBL] [Abstract][Full Text] [Related]
2. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
Mehdi SJ; Moerman-Herzog A; Wong HK
BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
[TBL] [Abstract][Full Text] [Related]
3. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.
Litvinov IV; Cordeiro B; Fredholm S; Ødum N; Zargham H; Huang Y; Zhou Y; Pehr K; Kupper TS; Woetmann A; Sasseville D
Cell Cycle; 2014; 13(18):2975-82. PubMed ID: 25486484
[TBL] [Abstract][Full Text] [Related]
4. Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL).
Wu J; Siddiqui J; Nihal M; Vonderheid EC; Wood GS
Arch Biochem Biophys; 2011 Apr; 508(2):185-91. PubMed ID: 21036138
[TBL] [Abstract][Full Text] [Related]
5. New
Velatooru LR; Hu CH; Bijani P; Wang X; Bojaxhi P; Chen H; Duvic M; Ni X
Cells; 2023 Sep; 12(19):. PubMed ID: 37830594
[TBL] [Abstract][Full Text] [Related]
6. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.
Manfè V; Biskup E; Rosbjerg A; Kamstrup M; Skov AG; Lerche CM; Lauenborg BT; Odum N; Gniadecki R
PLoS One; 2012; 7(1):e29541. PubMed ID: 22235305
[TBL] [Abstract][Full Text] [Related]
7. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
Gao J; Ren S; Choonoo G; Chen G; Frleta D; Zhong J; Gupta N; Sharma P; Oyejide A; Atwal GS; Macdonald L; Murphy A; Kuhnert F
Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37718909
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D in Cutaneous T-Cell Lymphoma.
Ødum AF; Geisler C
Cells; 2024 Mar; 13(6):. PubMed ID: 38534347
[TBL] [Abstract][Full Text] [Related]
9. TOX expression and role in CTCL.
McGirt LY; Degesys CA; Johnson VE; Zic JA; Zwerner JP; Eischen CM
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1497-502. PubMed ID: 27345620
[TBL] [Abstract][Full Text] [Related]
10. Embelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis.
Abdulrahman N; Leo R; Boumenar HA; Ahmad F; Mateo JM; Jochebeth A; Al-Sowaidi NK; Sher G; Ansari AW; Alam M; Uddin S; Ahmad A; Steinhoff M; Buddenkotte J
Leuk Lymphoma; 2023 Dec; 64(14):2236-2248. PubMed ID: 37708450
[TBL] [Abstract][Full Text] [Related]
11. The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression.
Litvinov IV; Kupper TS; Sasseville D
Exp Dermatol; 2012 Dec; 21(12):964-6. PubMed ID: 23171462
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway.
Kuttikrishnan S; Masoodi T; Ahmad F; Sher G; Prabhu KS; Mateo JM; Buddenkotte J; El-Elimat T; Oberlies NH; Pearce CJ; Bhat AA; Alali FQ; Steinhoff M; Uddin S
J Dermatol Sci; 2023 Nov; 112(2):83-91. PubMed ID: 37865581
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract][Full Text] [Related]
14. Cistanche phenylethanoid glycosides induce apoptosis and pyroptosis in T-cell lymphoma.
Tang Y; Zhao F; Zhang X; Niu Y; Liu X; Bu R; Ma Y; Wu G; Li B; Yang H; Wu J
Am J Cancer Res; 2024; 14(3):1338-1352. PubMed ID: 38590417
[No Abstract] [Full Text] [Related]
15. Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides.
Vitiello P; Sagnelli C; Ronchi A; Franco R; Caccavale S; Mottola M; Pastore F; Argenziano G; Creta M; Calogero A; Fiorelli A; Casale B; Sica A
Healthcare (Basel); 2023 Feb; 11(4):. PubMed ID: 36833148
[TBL] [Abstract][Full Text] [Related]
16. The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion.
Zhao L; Hsiao T; Stonesifer C; Daniels J; Garcia-Saleem TJ; Choi J; Geskin L; Rook AH; Wood GS
J Invest Dermatol; 2022 Dec; 142(12):3253-3261.e4. PubMed ID: 35787399
[TBL] [Abstract][Full Text] [Related]
17. E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.
Mustafa N; Mitxelena J; Infante A; Zenarruzabeitia O; Eriz A; Iglesias-Ara A; Zubiaga AM
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008734
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol.
Nihal M; Wu J; Stonesifer CJ; Daniels J; Choi J; Geskin L; Rook AH; Wood GS
J Invest Dermatol; 2022 Feb; 142(2):493-496.e7. PubMed ID: 34358529
[No Abstract] [Full Text] [Related]
19. Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma.
Lin M; Kowolik CM; Xie J; Yadav S; Overman LE; Horne DA
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282785
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma.
Zhang P; Zhang M
Front Oncol; 2021; 11():663961. PubMed ID: 34249700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
